2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine
C24H22N6O — CID 127037502
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine
2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine (PubChem CID 127037502) has the molecular formula C24H22N6O and a molecular weight of 410.48 g/mol. Its IUPAC name is 2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine |
|---|---|
| PubChem CID | 127037502 |
| Molecular Formula | C24H22N6O |
| Molecular Weight | 410.48 g/mol |
| Exact Mass | 410.19 |
| IUPAC Name | 2-methyl-6-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(triazol-2-yl)phenyl]ethyl]pyrimidin-4-amine |
| SMILES | Cc1nc(N[C@@H](C)c2cccc(-n3nccn3)c2)cc(-c2ccc3occ(C)c3c2)n1 |
| InChI | InChI=1S/C24H22N6O/c1-15-14-31-23-8-7-19(12-21(15)23)22-13-24(29-17(3)28-22)27-16(2)18-5-4-6-20(11-18)30-25-9-10-26-30/h4-14,16H,1-3H3,(H,27,28,29)/t16-/m0/s1 |
| InChIKey | GYUUJMFOZVQZKV-INIZCTEOSA-N |
| XLogP | 5.26 |
| TPSA | 81.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.48 |
| LogP ≤ 5 | 5.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127037502 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.